Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

BRIEF-Radius Health Initiates Phase 3 Trial Of Abaloparatide Injection For Male Osteoporosis [Reuters]

Radius Recycling, Inc. - Class A (RDUS) 
Last radius recycling, inc. - class a earnings: 2/27 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investors.radiuspharm.com
Company Research Source: Reuters
BRIEF-Radius Health Initiates Phase 3 Trial Of Abaloparatide Injection For Male Osteoporosis | Reuters Reuters Staff 1 Min Read March 30 (Reuters) - Radius Health Inc: * RADIUS HEALTH INITIATES PHASE 3 CLINICAL TRIAL OF ABALOPARATIDE INJECTION FOR THE TREATMENT OF MALE OSTEOPOROSIS Source text for Eikon: Further company coverage: All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. Š 2018 Reuters. All Rights Reserved. Show less Read more
Impact Snapshot
Event Time:
RDUS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for RDUS alerts
Opt-in for
RDUS alerts

from News Quantified
Opt-in for
RDUS alerts

from News Quantified